Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine in cancer-related fatigue
IRCT20181208041882N10Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of amantadine in cancer-related fatigue (CRF), sponsored by Shahid Sadoughi University of Medical Sciences. Started May 2022; status: completed.
02
Drugs
amantadine
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on IRCT20181208041882N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181208041882N10.